30 results
424B8
NMRD
Nemaura Medical Inc
11 Sep 23
Prospectus unintentially filed late
4:41pm
pandemic, which resulted in staff being reallocated to other approval requests associated with COVID-19. In April 2021 the FDA confirmed … process was subject to delays as a result of the CDRH being actively engaged in responding to the pandemic caused by COVID-19 which resulted in staff being
POS AM
NMRD
Nemaura Medical Inc
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
to the COVID-19 pandemic, which resulted in staff being reallocated to other approval requests associated with COVID-19. In April 2021 the FDA confirmed … that the approval process was subject to delays as a result of the CDRH being actively engaged in responding to the pandemic caused by COVID-19 which
424B4
z2es9 njry71ej
15 May 23
Prospectus supplement with pricing info
4:31pm
CORRESP
qdvm6eor8 l1m0wpvdh
10 May 23
Correspondence with SEC
12:00am
424B5
jr5y69npafln
1 Apr 22
Prospectus supplement for primary offering
4:29pm
424B5
7hde kot50u5n9n
23 Jul 21
Prospectus supplement for primary offering
4:28pm